<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00554697</url>
  </required_header>
  <id_info>
    <org_study_id>07-782</org_study_id>
    <nct_id>NCT00554697</nct_id>
  </id_info>
  <brief_title>Diabetes Mellitus Type II and Tissue Oxygenation</brief_title>
  <official_title>Influence of Diabetes Mellitus Type II on Tissue Oxygenation in the Perioperative Period</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Cleveland Clinic</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether diabetics have decreased amounts of oxygen&#xD;
      in the skin compared to non-diabetic individuals, and if the amount of oxygen in the skin&#xD;
      changes when given more oxygen to breathe around the time of surgery. To do this, the&#xD;
      investigators will be measuring the amount of oxygen in the skin of diabetic and non-diabetic&#xD;
      individuals who will be undergoing abdominal surgery lasting 2-4 hours. These measurements&#xD;
      will be taken at three different times.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The goal is to test the hypothesis that: 1) perioperative subcutaneous oxygenation (PsqO2) is&#xD;
      lower in diabetic than non-diabetic patients; and, 2) supplemental oxygen provides less&#xD;
      benefit in diabetic than non-diabetic patients.&#xD;
&#xD;
      We propose a prospective case-control study which will include 30 Type II diabetics matched&#xD;
      for age, sex, and race to 30 non-diabetic controls. Patients will be preselected from a&#xD;
      population undergoing abdominal surgery and given supplemental inspired oxygen of 30 - 80% to&#xD;
      PaO2 of approximately 150mmHg and/or 300mmHg at three timepoints in the perioperative period.&#xD;
      PsqO2 will be measured with an IV-sized probe inserted through a small incision made in the&#xD;
      skin. Data will be recorded and analyzed using unpaired two tailed t-test, Wilcoxon's ranked&#xD;
      sum test, or repeated-measures analysis of variance (ANOVA) test as appropriate.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Unable to recruit subjects&#xD;
  </why_stopped>
  <start_date>November 2007</start_date>
  <completion_date type="Actual">November 2008</completion_date>
  <primary_completion_date type="Actual">November 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Diabetes Mellitus Type II and Tissue Oxygenation</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">60</enrollment>
  <condition>Diabetes Mellitus, Type II</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        We will include 30 patients who have more than a five-year history of insulin-dependent&#xD;
        type-2 diabetes mellitus and 30 non-diabetic patients&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
        We will include 30 patients who have more than a five-year history of insulin-dependent&#xD;
        type-2 diabetes mellitus and 30 non-diabetic patients meeting the following criteria:&#xD;
&#xD;
          -  35 - 65 yrs old&#xD;
&#xD;
          -  BMI &lt; 30&#xD;
&#xD;
          -  ASA class I - III&#xD;
&#xD;
          -  Abdominal surgery scheduled to last between 2- 4 hours&#xD;
&#xD;
        For Non-diabetic group:&#xD;
&#xD;
        previous BMP within the last year demonstrating glucose &lt; 126mg/dL&#xD;
&#xD;
        For Diabetic group:&#xD;
&#xD;
          -  DMII defined as fasting plasma glucose of &gt; 126 mg/dL at time of diagnosis, now&#xD;
             requiring insulin&#xD;
&#xD;
          -  At least one diabetes associated vasculopathy: coronary artery disease, diabetic&#xD;
             nephropathy, hypertension, diabetic retinopathy, diffuse neuropathy, peripheral&#xD;
             vascular disease, or a history of stroke&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant&#xD;
&#xD;
          -  Immunocompromised: HIV/AIDS, on immunosuppressant therapy for any reason, or&#xD;
             post-organ transplantation.&#xD;
&#xD;
          -  Infection or fever, or on glucocorticoids&#xD;
&#xD;
          -  Malignancy currently requiring radiation or chemotherapy&#xD;
&#xD;
          -  Liver or renal failure&#xD;
&#xD;
          -  Pancreatic insufficiency, dysautonomia, thyroid disease, Raynaud's syndrome,&#xD;
             pathologic Allen-test, or any coagulopathies&#xD;
&#xD;
          -  Respiratory disease affecting ability to reach PaO2 of 300mmHg: COPD, emphysema,&#xD;
             cystic fibrosis, asthma, pneumonia, PE&#xD;
&#xD;
          -  Smoker within the past 6 months or current alcohol abuse&#xD;
&#xD;
          -  Allergy to local anesthetic&#xD;
&#xD;
          -  For diabetics: DMI, other specific subtype, and gestational diabetics&#xD;
&#xD;
          -  We will also exclude patients with epidural catheter, to avoid the influence of&#xD;
             regional anesthesia on tissue oxygenation [37, 38].&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel I Sessler, M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Andrea Kurz, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <verification_date>March 2017</verification_date>
  <study_first_submitted>November 6, 2007</study_first_submitted>
  <study_first_submitted_qc>November 6, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 7, 2007</study_first_posted>
  <last_update_submitted>March 14, 2017</last_update_submitted>
  <last_update_submitted_qc>March 14, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 16, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Cleveland Clinic</investigator_affiliation>
    <investigator_full_name>Andrea Kurz</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>tissue oxygenation</keyword>
  <keyword>perioperative</keyword>
  <keyword>outcome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

